glutamine has been researched along with Coronary Artery Disease in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (18.18) | 29.6817 |
2010's | 5 (45.45) | 24.3611 |
2020's | 4 (36.36) | 2.80 |
Authors | Studies |
---|---|
Chen, W; Dong, J; Ji, F; Li, H; Mu, H; Wang, S; Wang, X; Yang, R; Yu, X; Zhang, W | 1 |
Bojun, C; Hairong, C; Jieqin, Z; Shuling, L; Xingzhen, D; Yanhong, C; Zilin, J | 1 |
Brunkwall, L; Fernandez, C; Melander, O; Nilsson, PM; Orho-Melander, M; Ottosson, F; Smith, E | 1 |
Liu, H; Liu, S; Liu, Y; Qu, H; Song, X; Zhao, Z | 1 |
Dong, K; He, X; Hu, G; Liu, J; Osman, I; Wen, T; Xin, H; Yu, L; Zhang, F; Zhang, W; Zhou, J | 1 |
Ala-Korpela, M; Badeau, RM; Honka, MJ; Kangas, AJ; Lautamäki, R; Nuutila, P; Soininen, P; Stewart, M | 1 |
Qiu, HM; Qiu, JP; Zhang, CJ | 1 |
Dedoussis, G; Deltas, C; Kasparian, C; Lamnissou, K; Nastos, P; Nikolakis, D; Pantazopoulos, N; Vasilakou, M; Votteas, V | 1 |
Kalela, A; Kortelainen, ML; Kunnas, T; Lahtio, R; Nikkari, ST | 1 |
Garcia, JH; Guimarães, SB; Hissa, MN; Silva, RP; Vasconcelos, PR; Vasconcelos, RC | 1 |
Deryagin, MN; Efremov, SM; Karaskov, AM; Lomivorotov, VN; Lomivorotov, VV; Ponomarev, DN; Shmirev, VA; Svyatchenko, AV | 1 |
1 review(s) available for glutamine and Coronary Artery Disease
Article | Year |
---|---|
The gut microbiota-related metabolite phenylacetylglutamine associates with increased risk of incident coronary artery disease.
Topics: Adult; Aged; Chromatography, Liquid; Cohort Studies; Coronary Artery Disease; Female; Gastrointestinal Microbiome; Glutamine; Humans; Male; Mass Spectrometry; Metabolomics; Middle Aged; Prospective Studies; RNA, Ribosomal, 16S | 2020 |
4 trial(s) available for glutamine and Coronary Artery Disease
Article | Year |
---|---|
Efficacy and safety of Guhong injection for treating coronary microvascular disease: study protocol for a randomized controlled trial.
Topics: Adult; Aged; Anti-Inflammatory Agents; China; Coronary Artery Disease; Double-Blind Method; Female; Glutamine; Humans; Injections; Male; Middle Aged; Multicenter Studies as Topic; Plant Extracts; Prospective Studies; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome | 2020 |
Systemic metabolic markers and myocardial glucose uptake in type 2 diabetic and coronary artery disease patients treated for 16 weeks with rosiglitazone, a PPARγ agonist.
Topics: Aged; Blood Glucose; Coronary Artery Disease; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glutamine; Humans; Hypoglycemic Agents; Lactic Acid; Lipoproteins; Male; Middle Aged; Myocardium; PPAR gamma; Rosiglitazone; Thiazolidinediones; Time Factors | 2014 |
Preoperative glutamine infusion improves glycemia in heart surgery patients.
Topics: Aged; Analysis of Variance; Blood Glucose; Coronary Artery Disease; Double-Blind Method; Glutamine; Humans; Insulin; Middle Aged; Myocardial Revascularization; Preoperative Period; Prospective Studies; Sodium Chloride; Time Factors; Treatment Outcome | 2011 |
Does glutamine promote benefits for patients with diabetes mellitus scheduled for cardiac surgery?
Topics: Aged; Blood Glucose; Coronary Artery Bypass; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipeptides; Double-Blind Method; Fatty Acids; Female; Glutamine; Humans; Insulin Resistance; Insulin-Secreting Cells; Male; Middle Aged; Triglycerides; Troponin I | 2013 |
6 other study(ies) available for glutamine and Coronary Artery Disease
Article | Year |
---|---|
Serum glutamate and glutamine-to-glutamate ratio are associated with coronary angiography defined coronary artery disease.
Topics: Chromatography, Liquid; Coronary Angiography; Coronary Artery Disease; Glutamic Acid; Glutamine; Humans; Risk Factors; Severity of Illness Index; Tandem Mass Spectrometry | 2022 |
Phenylacetylglutamine is associated with the degree of coronary atherosclerotic severity assessed by coronary computed tomographic angiography in patients with suspected coronary artery disease.
Topics: Computed Tomography Angiography; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Glutamine; Humans; Plaque, Atherosclerotic; Predictive Value of Tests; Prospective Studies; Registries; Severity of Illness Index; Tomography, X-Ray Computed | 2021 |
TEAD1 (TEA Domain Transcription Factor 1) Promotes Smooth Muscle Cell Proliferation Through Upregulating SLC1A5 (Solute Carrier Family 1 Member 5)-Mediated Glutamine Uptake.
Topics: Amino Acid Transport System ASC; Animals; Biological Transport; Cell Proliferation; Coronary Artery Disease; Disease Models, Animal; DNA-Binding Proteins; Glutamine; Humans; Mechanistic Target of Rapamycin Complex 1; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Minor Histocompatibility Antigens; Myocytes, Smooth Muscle; Neointima; RNA Interference; Signal Transduction; TEA Domain Transcription Factors; Transcription Factors; Transcriptional Activation; Up-Regulation | 2019 |
Relationship of polymorphisms in the cholesteryl ester transport protein gene R451Q with coronary heart disease and diabetes in Uyghur and Han Chinese.
Topics: Adult; Aged; Arginine; Asian People; Case-Control Studies; Cholesterol Ester Transfer Proteins; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Gene Frequency; Glutamine; Humans; Lipids; Male; Middle Aged; Polymorphism, Single Nucleotide | 2014 |
Lack of association between endothelial nitric oxide synthase gene polymorphisms and risk of premature coronary artery disease in the Greek population.
Topics: Adult; Age Factors; Aged; Alleles; Asparagine; Case-Control Studies; Coronary Artery Disease; Endothelium, Vascular; Exons; Female; Glutamine; Greece; Humans; Introns; Male; Middle Aged; Minisatellite Repeats; Myocardial Infarction; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Risk Factors | 2008 |
Gln27Glu variant of Beta2-adrenoceptor gene affects male type fat accumulation in women.
Topics: Adolescent; Adult; Body Mass Index; Coronary Artery Disease; Female; Genetic Predisposition to Disease; Genotype; Glutamic Acid; Glutamine; Humans; Intra-Abdominal Fat; Male; Middle Aged; Polymorphism, Genetic; Receptors, Adrenergic, beta-2; Young Adult | 2009 |